Differential roles of PKC alpha and PKC epsilon in controlling the gene expression of Nox4 in human endothelial cells

作者：Xu Hui; Goettsch Claudia; Xia Ning; Horke Sven; Morawietz Henning; Froestennann Ulrich; Li Huige^*

来源：Free Radical Biology and Medicine, 2008, 44(8): 1656-1667.

DOI：10.1016/j.freeradbiomed.2008.01.023

• endothelium
• gene expression
• reactive oxygen species
• NADPH oxidase
• protein kinase C
• free radicals

NADPH oxidases are major sources of superoxide in the vascular wall. This study investigates the role of protein kinase C (PKC) in regulating gene expression of NADPH oxidases. Treatment of human umbilical vein endothelial cells (HUVEC) and HUVEC-derived EA.hy 926 endothelial cells with phorbol 12-myristate 13-acetate (PMA) or phorbol 12,13-dibutyrate led to a PKC-dependent biphasic expression of the gp91phox homolog Nox4. A downregulation of Nox4 was observed at 6 h and an upregulation at 48 h after phorbol ester treatment. The early Nox4 downregulation was associated with a reduced superoxide production, whereas the late Nox4 upregulation was accompanied by a clear enhancement of superoxide. PMA activated the PKC isoforms a and e in HUVEC and EA.hy 926 cells. Knockdown of PKC epsilon by siRNA prevented the early downregulation of Nox4, whereas knockdown of PKC alpha selectively abolished the late Nox4 upregulation. Vascular endothelial growth factor (VEGF), which activates PKC alpha but not PKC epsilon in HUVEC, increased Nox4 expression without the initial downregulation. VEGF-induced Nox4 upregulation was associated with an enhanced proliferation and angiogenesis of HUVEC. Both effects could be reduced by inhibition of NADPH oxidase. Thus, a selective inhibition/knockdown of PKC alpha may represent a novel therapeutic strategy for vascular disease.

• 出版日期2008-4-15
• 单位华中科技大学